EDAP to Announce Fourth Quarter and Full Year 2025 Financial Results

Company to host conference call and webcast on March 25, 2026

Published on Mar. 4, 2026

EDAP TMS SA, the global leader in robotic energy-based therapies, announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025, before market open on Wednesday, March 25, 2026. The company will also host a conference call and webcast on the same day at 8:30 a.m. EDT.

Why it matters

As a leading provider of minimally invasive medical devices, EDAP's financial performance and product updates are closely watched by investors and the healthcare industry. The announcement of its 2025 results will provide insight into the company's growth and strategic direction.

The details

EDAP will report its Q4 and full-year 2025 financial results on March 25, 2026. The conference call and webcast will feature remarks from CEO Ryan Rhodes, CFO Ken Mobeck, and Chief Accounting Officer François Dietsch.

  • EDAP will release its Q4 and full-year 2025 financial results on March 25, 2026.
  • The conference call and webcast will take place on March 25, 2026 at 8:30 a.m. EDT.

The players

EDAP TMS SA

A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes, and distributes minimally invasive medical devices using ultrasound technology.

Ryan Rhodes

Chief Executive Officer of EDAP TMS SA.

Ken Mobeck

Chief Financial Officer of EDAP TMS SA.

François Dietsch

Chief Accounting Officer of EDAP TMS SA.

Got photos? Submit your photos here. ›

What’s next

Investors and analysts will be closely watching EDAP's Q4 and full-year 2025 financial results to assess the company's performance and growth prospects.

The takeaway

EDAP's announcement of its 2025 financial results demonstrates the company's continued leadership in the robotic energy-based therapy market and its commitment to providing updates to investors and the healthcare industry.